Display Settings:

Format

Send to:

Choose Destination
    Dev Dyn. 2006 Jan;235(1):50-9.

    Transforming growth factor-beta stimulates epithelial-mesenchymal transformation in the proepicardium.

    Source

    Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6600, USA.

    Abstract

    The proepicardium (PE) migrates over the heart and forms the epicardium. A subset of these PE-derived cells undergoes epithelial-mesenchymal transformation (EMT) and gives rise to cardiac fibroblasts and components of the coronary vasculature. We report that transforming growth factor-beta (TGFbeta) 1 and TGFbeta2 increase EMT in PE explants as measured by invasion into a collagen gel, loss of cytokeratin expression, and redistribution of ZO1. The type I TGFbeta receptors ALK2 and ALK5 are both expressed in the PE. However, only constitutively active (ca) ALK2 stimulates PE-derived epithelial cell activation, the first step in transformation, whereas caALK5 stimulates neither activation nor transformation in PE explants. Overexpression of Smad6, an inhibitor of ALK2 signaling, inhibits epithelial cell activation, whereas BMP7, a known ligand for ALK2, has no effect. These data demonstrate that TGFbeta stimulates transformation in the PE and suggest that ALK2 partially mediates this effect.

    2005 Wiley-Liss, Inc.

    PMID:
    16245329
    [PubMed - indexed for MEDLINE]
    PMCID: PMC3160345
    Free PMC Article

    Images from this publication.See all images (7) Free text

    Fig. 5
    Fig. 6
    Fig. 1
    Fig. 4
    Fig. 7
    Fig. 2
    Fig. 3

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk